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Differential role of glutaredoxin and thioredoxin in metabolic oxidative
stress-induced activation of apoptosis signal-regulating kinase 1
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Redox-sensing molecules such as thioredoxin (TRX) and gluta-
redoxin (GRX) bind to apoptosis signal-regulating kinase 1
(ASK1) and suppress its activation. Glucose deprivation disrupted
the interaction between TRX/GRX and ASK1 and subsequently
activated the ASK1–stress-activated protein kinase/extracellu-
lar-signal-regulated kinase kinase–c-Jun N-terminal kinase
1 (JNK1) signal-transduction pathway. L-Buthionine-(S,R)-
sulphoximine, which decreases intracellular glutathione content,
enhanced glucose deprivation-induced activation of JNK1 by
promoting the dissociation of TRX, but not GRX, from ASK1.
Treatment of cells with exogenous glutathione disulphide ester
resulted in the dissociation of GRX, but not TRX, from ASK1
and the subsequent activation of JNK1. Nonetheless, overexpres-
sion of calatase, an H2O2 scavenger, inhibited JNK1 activation and
cytotoxicity as well as the dissociation of TRX and GRX from
ASK1 during combined glucose deprivation and L-buthionine-
(S,R)-sulphoximine treatment. Taken together, glucose depriv-
ation-induced metabolic oxidative stress may activate ASK1
through two different pathways: glutathione-dependent GRX–
ASK1 and glutathione-independent TRX–ASK1 pathways.
Key words: apoptosis signal-regulating kinase 1, glucose depri-
vation, glutaredoxin, glutathione, metabolic oxidative stress,
thioredoxin.
INTRODUCTION
We have observed previously that glucose deprivation increases
the intracellular levels of hydroperoxide and glutathione
disulphide (GSSG) [1,2]. The increased steady-state levels of
hydroperoxide activate signal-transduction pathways, such as
stress-activated protein kinase (SAPK), and subsequently promote
expression of genes associated with stress responses as well as
cytotoxicity [1,3,4]. However, a fundamental question, which
remains unanswered, is how metabolic oxidative stress triggers
signal-transduction pathways in mammalian cells. Recent studies
have revealed that a conserved family of activator protein-1
(AP-1)-like factors (named yAP-1) are redox-sensing molecules
in yeast [5]. H2O2 activates yAP-1 through disulphide formation
of two cysteine residues, which is essential for yAP-1 activation
after oxidative stress [6]. In Escherichia coli, SoxR and OxyR are
reduction–oxidation (redox) status sensors and are transcription
factors that activate antioxidant genes in response to superoxide
anion and H2O2 [7]. SoxR is activated by superoxide anion-
generating agents or by nitric oxide through two consecutive steps
of gene activation [8,9]. Two forms of SoxR have been charac-
terized: Fe-SoxR contains non-haem iron and apo-SoxR is devoid
of iron and other metals [10]. Both forms of SoxR bind to the
target in vivo, namely the soxS promoter. However, only Fe-SoxR
stimulated transcription initiation at soxS [11]. The Fe-SoxR is
a homodimer, and each monomer has a redox-active [2Fe-2S]
cluster. The oxidation state of [2Fe-2S] centre controls its activity
as a transcription activator independent of its DNA-binding
ability [12,13]. Unlike SoxR, OxyR does not contain metal ions
and other prosthetic groups in the redox-active centre. Instead,
OxyR molecules form an intramolecular disulphide bond between
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cysteine residues when the environment becomes oxidizing.
Formation of an intramolecular disulphide bond between residues
Cys199 and Cys208 leads to a conformational change, which
activates the OxyR transcription factor [7]. Similar molecules
such as the thiol-disulphide oxidoreductase family of proteins
[thioredoxin (TRX), glutaredoxin (GRX) and protein disulphide-
isomerase] are found in eukaryotic cells. Several studies show that
these molecules contain two redox-active half-cysteine residues,
-Cys-Gly-Pro-Cys- or -Cys-Pro-Tyr-Cys-, in an active centre
[14,15].
In the present study, we hypothesized that GRX and TRX
are sensor molecules that recognize metabolic oxidative stress
and co-operatively regulate the activation of apoptosis signal-
regulating kinase 1 (ASK1) in mammalian cells. ASK1 is a
mitogen-activated protein kinase (MAPK) kinase kinase that
can activate both SAPKs [via activation of MAPK kinase 4/7
(MKK4/7)] and p38 MAPKs (via activation of MKK3/6) [16].
Previous studies have revealed that TRX is a negative regulator
of ASK1 [17]. It binds directly to the N-terminal portion of
ASK1 and inhibits ASK1 kinase activity [17]. Our recent studies
have shown that GRX also directly binds to ASK1 and inhibits
ASK1 activation [18]. However, unlike TRX, GRX binds to the
C-terminal portion of ASK1 [18]. Our studies have also shown
that the interaction between GRX and ASK1 is dependent on
the redox status of GRX during glucose deprivation. GRX may
recognize metabolic oxidative stress through catalytic reactions
with GSSG [18]. As mentioned previously, GRX contains
two redox-active half-cysteine residues, Thr-Cys-Pro-Tyr-Cys-
Arg in an active centre [19]. However, unlike TRX, GRX is
highly selective for glutathione-containing mixed disulphides,
and its catalytic cycle involves a covalent glutathionyl-enzyme
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disulphide intermediate (GRX-SSG) rather than an intramolecu-
lar disulphide at its active site [20]. GRX may recognize glucose
deprivation-induced metabolic oxidative stress through catalytic
reactions with GSSG and form GRX-SSG. Subsequently, GRX
is interconverted between GRX-SSG and an intramolecular
disulphide form of GRX (GRX-[S-S]) by side reaction [20]. The
oxidized GRX, GRX-SSG or GRX-[S-S], dissociates from ASK1.
Unlike GRX, TRX may directly recognize H2O2 [21] or oxidized
proteins. The dissociation of GRX and TRX from ASK1 may
result in the activation of ASK1.
The tripeptide L-γ -glutamyl-L-cysteinyl-glycine or GSH, an
ubiquitous thiol, acts as a major non-enzymic antioxidant and
plays a major role in maintaining the intracellular redox state
[22–24]. It is well known that L-buthionine-(S,R)-sulphoximine
(BSO), a specific inhibitor of γ -glutamylcysteine synthetase,
reduces the intracellular GSH content by inhibiting the first step
and rate-limiting step of GSH synthesis [25,26]. In the present
study, we employed BSO to investigate a possible involvement of
glutathione in the regulation of the interaction between GRX/TRX
and ASK1. Our studies demonstrate that BSO inhibits glucose
deprivation-induced dissociation of GRX, but not TRX, from
ASK1. Interestingly, BSO enhances glucose deprivation-induced
c-Jun N-terminal kinase (JNK) activation. In contrast, treatment of
the cells with exogenous GSSG ester caused dissociation of GRX,
but not TRX, from ASK1 as well as activation of JNK1. However,
overexpression of catalase prevents dissociation of GRX and
TRX from ASK1 as well as ASK1 activation during glucose
deprivation. Taken together, the dissociation of both regulators
from ASK1 is not required for ASK1 activation. These results
suggest that release of GRX and TRX from ASK1 occurs via




Media, serum, Protein A–agarose and lipofectAMINETM reagent
were purchased from Life Technologies (Gathersburg, MD,
U.S.A.). Rat anti-haemagglutinin (HA) (clone 3F10) and mouse
anti-HA antibody (clone 12CA5) were obtained from Roche
(Mannheim, Germany). Glutathione–Sepharose 4B and enhanced
chemiluminescence reagent were purchased from Amersham
Pharmacia Biotech (Arlington Heights, IL, U.S.A.). Rabbit anti-
catalase antibody and Protein G–agarose were obtained from
Calbiochem (San Diego, CA, U.S.A.). Goat anti-GRX and
anti-TRX antibodies were obtained from American Diagnostica
(Greenwich, CT, U.S.A.). Monoclonal mouse anti-actin antibody
was purchased from ICN (Costa Mesa, CA, U.S.A.). Rabbit
anti-ACTIVE JNK antibody was purchased from Promega
(Madison, WI, U.S.A.). Anti-His5 mouse IgG1 and anti-ASK1
antibody were obtained from Qiagen (Valencia, CA, U.S.A.) and
Alexis Corp. (Lausen, Switzerland) respectively. Anti-γ -glutamyl
transpeptidase (GGT) antibody was a gift from Dr A. A. Stark
(Tel-Aviv University, Israel). All other reagents were purchased
from Sigma–Aldrich (St. Louis, MO, U.S.A.).
Methods
Cell culture and treatment with glucose deprivation
Human prostate adenocarcinoma cells (DU-145) were cultured
in Dulbecco’s modified Eagle’s medium with 10% (v/v) foetal
bovine serum and 26 mM sodium bicarbonate for monolayer cell
culture. The cells were maintained in a humidified atmosphere
containing 5%CO2 and air at 37 ◦C. Cells were rinsed three times
with PBS and then exposed to glucose-free Dulbecco’s modified
Eagle’s medium containing 10% dialysed foetal bovine serum.
Treatment with BSO
Cells were replaced with a fresh medium containing BSO. Sham
group also had a complete medium change solely excluding BSO.
Vector construction
pcDNA3-His-GRX was made by inserting EcoRI fragment from
pQE-GRX (a gift from Dr J. J. Mieyal, Case Western Reserve
University, Cleveland, OH, U.S.A.) into EcoRI-cut pcDNA3.
An N-terminally His-tagged 324 bp human TRX gene was
isolated from pcDNA-His-TRX (a gift from Dr J. Yodoi, Kyoto
University, Japan) digestion with EcoRI and cloned into the
EcoRI site of pAdlox shuttle vector [27]. pcDNA3-His-GRX
was made by inserting EcoRI fragment from pQE-GRX into
EcoRI-cut pcDNA3. pAdlox-His-GRX was made by inserting
HindIII–XbaI fragment from pcDNA3-His-GRX into HindIII–
XbaI-cut pAdlox shuttle vector containing N-terminal fused form
with hexahistidine (His6) tag. pcDNA3-HA-ASK1 was kindly
provided by Dr H. Ichijo (Tokyo Medical and Dental University,
Tokyo, Japan). pAdlox-HA-ASK1 was made by inserting SpeI–
XbaI fragment from pcDNA3-HA-ASK1 into XbaI-cut pAdlox.
The complete shuttle vector was co-transfected into CRE8 cells
with ψ5 viral genomic DNA for homologous recombination as
described below.
Adenoviral vectors
The adenovirus construct containing the transgene for human
catalase was kindly provided by Dr Beverly Davidson (Gene
Transfer Vector Core, University of Iowa, Iowa City, IA,
U.S.A.). All other recombinant adenoviruses were constructed
by employing the Cre-lox recombination system [27]. The
selective cell line CRE8 has a β-actin-based expression
cassette driving a Cre recombinase gene with an N-terminal
nuclear localization signal stably integrated into HEK-293
cells. Transfections were done using lipofectAMINETM. Cells
(5×105) were split into a 6-well plate 1 day before transfection.
For the production of recombinant adenovirus, 2 µg of SfiI–
ApaI-digested Adlox/ASK1 fragment or SfiI–ApaI-digested
Adlox/TRX or SfiI-digested Adlox/GRX and 2 µg of ψ5
viral genomic DNA were co-transfected into CRE8 cells. The
recombinant adenoviruses were generated by intermolecular
homologous recombination between the shuttle vector and ψ5
viral DNA. A new virus has an intact packaging site and
carries a recombinant gene. Plaques were harvested, analysed
and purified. The insertion of HA–ASK1 or His–GRX/His–TRX
into adenovirus was confirmed by Western-blot analysis after
infection of corresponding recombinant adenovirus into DU-145
cells. Modifications of the native parts of the proteins did not
occur by tagging HA or His at their N-termini.
In vivo binding of ASK1 and GRX
To examine the interaction between ASK1 and TRX or GRX,
adenovirus of HA-tagged ASK1 (Ad.HA–ASK1) at an MOI
(multiplicity of infection, i.e. number of viral particles per cell)
of 10 and His-tagged TRX or GRX (Ad.His–TRX or Ad.His–
GRX) at an MOI of 30 were co-infected into DU-145 cells in
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10 cm culture plates. For immunoprecipitation, cells were lysed
in buffer containing 150 mM NaCl, 20 mM Tris/HCl (pH 7.5),
10 mM EDTA, 1% Triton X-100, 1% deoxycholate, 1 mM
PMSF, 80 µM aprotinin and 2 mM leupeptin, and the lysates
were incubated with 2 µg of anti-His5 mouse IgG1 for 2 h. For
immunoprecipitation with HA–ASK1, the lysates were incubated
with 0.5 µg of rat anti-HA for 2 h. After the addition of Protein
G–agarose, the lysates were incubated for an additional 2 h. The
beads were washed three times with the lysis buffer, separated by
SDS/PAGE, and immunoblotted with rat anti-HA or mouse anti-
His5 or mouse anti-HA antibodies. The proteins were detected
with the enhanced chemiluminescence reaction. To confirm the
interaction between endogenous ASK1 and GRX or TRX, cell
lysates were immunoprecipitated with 2 µg of anti-GRX or anti-
TRX antibodies followed by immunoblotting with anti-ASK1,
anti-GRX or anti-TRX antibody. To examine the effect of BSO
on glucose deprivation-induced dissociation of TRX or GRX from
ASK1, Ad.HA–ASK1-co-infected DU-145 cells and Ad.His–
TRX- or Ad.His–GRX-co-infected DU-145 cells were exposed
to glucose-free medium after BSO pretreatment for 24 h.
In vitro kinase assay
The plasmid containing glutathione S-transferase (GST)–human
JNK1 for bacterial fusion protein was constructed in pGEX-
4T-1 by inserting HindIII–XbaI fragment followed by Klenow
treatment from pcDNA3-JNK1. The expression of GST–JNK1
protein was confirmed by Western-blot analysis and purified
by using glutathione–Sepharose 4B. GST–SEK1 (where SEK1
represents SAPK/extracellular-signal-regulated kinase kinase)
was purified from ten 100 mm plates of HEK-293 cells transfected
with the pEBG/SEK1 (kindly provided by J. M. Kyriakis,
Massachusetts General Hospital, Charlestown, MA, U.S.A.), and
the purification step was performed as described previously [28].
DU-145 cells were infected with Ad.HA–ASK1 at an MOI of 10
followed by treatment with BSO for 24 h. After 48 h infection,
cells were lysed in a buffer solution containing 20 mM Tris/HCl
(pH 7.5), 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1%
Triton X-100, 0.5% deoxycholate, 1 mM sodium orthovanadate,
1 mM PMSF and protein inhibitor cocktail solution. Cell
extracts were clarified by centrifugation, and the supernatants
immunoprecipitated with mouse anti-HA antibody and Protein A–
agarose. The beads were washed twice with a solution containing
150 mM NaCl, 20 mM Tris/HCl (pH 7.5), 5 mM EGTA, 1 mM
sodium orthovanadate and 1 mM PMSF and were washed once
with the kinase buffer solution, and then they were subjected
to kinase assays. To measure immunocomplex activity, 0.2 µg
of GST–SEK1 is first incubated with the immunocomplexes for
10 min at 30 ◦C in a final volume of 25 µl of a solution containing
20 mM Tris/HCl (pH 7.5), 20 mM MgCl2 and 100 µM ATP,
and is subsequently incubated with 1 µg of GST–JNK1 for
10 min at 30 ◦C. Thereafter, the activated complex is subjected
to SDS/PAGE, and the phosphorylated JNK is analysed by rabbit
anti-ACTIVE JNK antibody. To determine the amount of ASK1
protein in the same sample, the upper part of the SDS/PAGE
(>116 kDa) was cut and immunoblotted with the rat anti-HA
antibody.
Preparation of GSSG ester
GSSG ester was prepared from 10 mM GSH ethyl ester (Sigma–
Aldrich) by treatment with 100 mM H2O2 for 1 h followed by
treatment with 10 units/ml catalase for 1 h [29]. Previous studies
Figure 1 Effect of BSO on glucose deprivation-induced cytotoxicity
DU-145 cells were treated with various concentrations of BSO (0–500 µM) for 24 h and then
exposed to glucose-free medium for 8 h (–glucose) or 24 h (–glucose). Cell survival was
determined using the Trypan Blue exclusion assay. The data are a compilation of two separate
experiments. +Glucose, cells were treated only with BSO.
have shown that H2O2 treatment converts the GSH ester into the
GSSG ester with a yield in excess of 90% [29].
Immunoblot analysis
Cell lysates were subjected to SDS/PAGE (12% gel) under
reducing conditions, and the proteins in the gels were transferred
on to a PVDF membrane. The membranes were incubated with
7% (w/v) skimmed milk in PBST [PBS containing 0.1% (v/v)
Tween 20] and then reacted with primary antibodies. After
washing three times with PBST, the membranes were incubated
with horseradish peroxidase-conjugated anti-IgG. Proteins in the
membranes were then visualized using the enhanced chemi-
luminescence (ECL R©) reagent following the manufacturer’s
instructions.
RESULTS
BSO enhances glucose deprivation-induced cytotoxicity
The effect of BSO on glucose deprivation-induced cytotoxicity
was assessed in DU-145 cells. Cells were treated with various
concentrations of BSO for 24 h, followed by glucose deprivation
for 8 or 24 h. Figure 1 shows that little or no cytotoxicity was
observed with BSO alone up to 500 µM. In contrast, glucose
deprivation-induced cell death was enhanced by BSO. For exam-
ple, the survival of the cells decreased from 66 to 46% or 32 to
5% by 8 or 24 h of incubation respectively in glucose-free
medium containing 200 µM BSO, which reduces the intracellular
glutathione content by 99% [18]. BSO-enhanced cytotoxicity was
concentration-dependent (Figure 1).
BSO promotes glucose deprivation-induced JNK activation
We have observed previously that glucose deprivation activates
JNK1 and overexpression of its dominant-negative mutant
inhibits metabolic oxidative stress-induced cytotoxicity [3].
These results suggest that JNK-signalling pathways control
the expression of proteins contributing to cell death mediated
by metabolic oxidative stress during glucose deprivation. We
further examined whether combined BSO and glucose deprivation
enhance JNK1 activation, which may result in enhancement of
glucose deprivation-induced cytotoxicity. Western blots using an
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Figure 2 Effect of BSO on glucose deprivation-induced JNK1 activation
DU-145 cells were treated with or without 200 µM BSO for 24 h and then exposed to glucose-free medium for various time periods (0–2 h). Cell lysates containing equal amounts of protein (20 µg)
were separated by SDS/PAGE and immunoblotted with anti-phospho-JNK or anti-JNK1 antibody.
Figure 3 Effect of BSO on glucose deprivation-induced ASK1 activation
DU-145 cells were infected with adenoviral vectors containing HA-tagged ASK1 (Ad.HA–ASK1)
at an MOI of 10. After 24 h incubation, cells were treated with (+) or without (–) 200 µM BSO for
24 h and then exposed to glucose-free medium for 1 h. Lysates were immunoprecipitated with
anti-HA antibody. The immunocomplex was incubated with GST–SEK1 followed by GST–JNK1.
Active JNK1 was detected with anti-phospho-JNK antibody. ASK1 was detected with anti-HA
antibody. Lane 1, uninfected control cells. IP, immunoprecipitation.
antibody specific for the active form of JNK1 (anti-ACTIVE
JNK1 antibody) showed that glucose deprivation-induced JNK1
activation was observed within 5 min and its activation was
maintained for more than 2 h (Figure 2). Figure 2 also shows
that BSO enhanced glucose deprivation-induced JNK activation.
These results were similar to our previous reports using MCF-
7/ADR cells [3].
Glucose deprivation in combination with BSO enhances
ASK1 activity
Previous studies have shown that ASK1 activates SEK1-JNK- and
MKK3/MKK6-p38-signalling cascades [16,17,30]. To examine
whether the enhanced JNK/p38 activation by treatment with BSO
in combination with glucose deprivation is mediated through the
activation of ASK1, DU-145 cells were infected with Ad.HA–
ASK1 at an MOI of 10 and then treated with 200 µM BSO for 24 h
followed by 1 h of exposure to glucose-free medium. Cell lysates
were immunoprecipitated with anti-HA antibody. ASK1 enzyme
activity was measured by an immunocomplex kinase assay using
GST–SEK1 and GST–JNK1 as sequential substrates. Activated
JNK1 was detected by anti-ACTIVE JNK antibody. Results from
in vitro kinase assay show that glucose deprivation activated JNK1
(Figure 3, lane 3) and its activation was enhanced by treatment
with BSO (Figure 3, lane 5). These results indicate that glucose
deprivation-induced JNK1 activation is mediated through the
ASK1–SEK1–JNK1 signal-transduction pathway. BSO facilitates
this signal-transduction pathway by promoting ASK1 activity.
Effect of BSO on glucose deprivation-induced dissociation
of GRX or TRX from ASK1
Previous studies have shown that GRX and TRX bind to the C- and
N-terminal portions of ASK1 respectively [17,18]. We examined
whether GRX or TRX dissociates from ASK1 during glucose
deprivation and whether GSSG plays any regulatory role in
the interaction between them. Results from immunoprecipitation
followed by immunoblotting show that TRX and GRX dissociated
from ASK1 during glucose deprivation (Figures 4A–4C, lane 3).
BSO inhibited dissociation of GRX, but not TRX, from ASK1
(Figures 4A–4C, lane 5). These results suggest that glutathione
plays a regulatory role in the interaction between GRX, but not
TRX, and ASK1. These results also indicate that TRX and GRX
sense metabolic oxidative stress through different pathways. To
examine whether endogenous ASK1 and GRX or TRX interact,
cells were lysed and immunoprecipitated with anti-GRX or anti-
TRX antibody followed by Western blotting with anti-ASK1,
anti-GRX or anti-TRX antibody. The presence of endogenous
GRX, TRX and ASK1 protein was detected (Figure 4D, lower
panel). Figure 4(D) shows that indeed the endogenous factors
interact. Figure 4(D) also shows that endogenous GRX as well
as TRX dissociated from endogenous ASK1 during glucose
deprivation (Figure 4D, upper panel, lane 2 versus lane 3).
Effect of BSO on H2O2-induced dissociation of GRX
or TRX from ASK1
Previous studies have shown that glucose deprivation-induced
metabolic oxidative stress results from an increase in reactive
oxygen species (ROS), such as superoxide anion or H2O2
[1]. Superoxide anion is known to be rapidly dismutated to
H2O2 by superoxide dismutase, and then H2O2 is transformed
to water by catalase or glutathione peroxidase in the presence of
GSH. To examine whether H2O2 is responsible for the dissociation
of GRX or TRX from ASK1, DU-145 cells were treated with
5 mM H2O2 and the immunocomplex analysis was performed.
As shown in Figure 5, GRX and TRX dissociated from ASK1
on treatment with H2O2 (Figure 5A, lanes 3 and 7; Figure 5B,
lane 3). Interestingly, BSO inhibited dissociation of GRX, but
c© 2003 Biochemical Society
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Figure 4 Effect of BSO on glucose deprivation-induced dissociation of GRX or TRX from ASK1
DU-145 cells were co-infected with Ad.HA–ASK1 at an MOI of 10 and adenoviral vectors containing His-tagged GRX (Ad.His–GRX) and/or His-tagged TRX (Ad.His–TRX) at an MOI of 30. After 24 h
incubation, cells were treated with (+) or without (–) 200 µM BSO for 24 h and then exposed to glucose-free medium for 1 h. (A, B) Lysates were immunoprecipitated with anti-His antibody, and
immunoblotted with anti-HA (upper panel) or anti-His antibody (lower panel). (C) Lysates were immunoprecipitated with anti-HA antibody, and immunoblotted with anti-His (upper panel) or anti-HA
antibody (lower panel). (D) To confirm the interaction between endogenous ASK1 and GRX or TRX, uninfected cells were exposed to complete medium or glucose-free medium for 1 h, and cell
lysates were immunoprecipitated with 2 µg of anti-GRX, anti-TRX or anti-mouse antibody, and then immunoblotted with anti-ASK1, anti-GRX or anti-TRX antibody (upper panels). Endogenous level
of ASK1, GRX or TRX was examined by Western-blot analysis with anti-ASK1, anti-GRX or anti-TRX antibody (lower panels). IP, immunoprecipitation.
not TRX, from ASK1 during treatment with H2O2 (Figure 5A,
lanes 4 and 8; Figure 5B, lane 5). These results suggest that
dissociation of GRX is dependent on the presence of glutathione,
probably GSSG. Unlike GRX, TRX may directly sense H2O2 or
other oxidized molecules.
GSSG-mediated JNK activation
To examine the involvement of GSSG in the activation of
the ASK1–MEK–MAPK signal-transduction pathway (where
MEK is MAPK/extracellular-signal-regulated kinase kinase), we
treated cells with exogenous GSSG ester. Before this experiment,
we measured the cellular level of GGT. GGT is an 87 kDa type II
transmembrane ectoenzyme. It is a heterodimer composed of 65
and 22 kDa subunits. Most of the molecule is extracellular, and its
role is to cleave glutamyl groups from extracellular GSH or GSSG.
Thus it is necessary to examine whether DU-145 cells have GGT
activity. If they do, then exogenous glutathione derivatives are
likely to be degraded rapidly. Figure 6 shows that human prostate
cancer cell lines (DU-145, LNCap and PC-3) do not contain any
detectable GGT.
To examine the effect of GSSG, Ad.HA–ASK1- and Ad.His–
GRX- or Ad.His–TRX-infected DU-145 cells were treated
with 1 mM GSSG ester for 1 h. Cells were harvested and
immunoprecipitated with anti-His antibody. Figure 7(A) shows
that treatment with GSSG ester led to dissociation of GRX, but
not TRX, from ASK1. Interestingly, the maximum reduction in the
binding of GRX to ASK1 was approx. 50% (Figure 7A, lane 3
versus lane 2). This relatively inefficient inhibition may have
resulted from the short treatment time (i.e. bolus of GSSG ester).
Activation of JNK1 was also observed in these cells (Figure 7B).
These results show that GSSG is responsible for dissociation
of GRX, but not TRX, from ASK1 and subsequently JNK1
activation.
Overexpression of catalase suppresses glucose
deprivation-induced JNK1 activation as well as cytotoxicity
Catalase, a tetrameric Fe (III)-haem protein, is found in the
cytosol and serves as an efficient scavenger of H2O2. It has
been reported that catalase becomes important when glutathione
is depleted. These results suggest that catalase can serve as a
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Figure 5 Effect of BSO on H2O2-induced dissociation of GRX or TRX from
ASK1
DU-145 cells were co-infected with Ad.His–GRX at an MOI of 30, Ad.His–TRX at an MOI of
30 and Ad.HA–ASK1 at an MOI of 10. After 24 h incubation, cells were treated with (+) or
without (–) 200 µM BSO for 24 h and then exposed to 5 mM H2O2 for 1 h. (A) Lysates
were immunoprecipitated with anti-His antibody, and immunoblotted with anti-HA (upper
panel) or anti-His antibody (lower panel). (B) Lysates were immunoprecipitated with anti-
HA antibody, and immunoblotted with anti-His (upper panel) or anti-HA antibody (lower panel).
IP, immunoprecipitation.
Figure 6 Immunoblot detection of GGT in HEK-293 cells and various human
prostate cancer cells (DU-145, LNCap and PC-3)
Lysates containing equal amounts of protein (20 µg) were separated by SDS/PAGE and
immunoblotted with anti-GGT or anti-actin antibody. Lane 1, HEK-293 cells; lane 2, DU-145
cells; lane 3, LNCap cells; lane 4, PC-3 cells.
secondary defence when the glutathione system becomes limiting
[22]. To examine whether glucose deprivation-induced JNK
activation would be suppressed by overexpression of catalase,
DU-145 cells were infected with adenoviral vectors containing
catalase at an MOI of 5. Figure 8 shows that overexpression
of catalase inhibited glucose deprivation-induced JNK1 acti-
Figure 7 GSSG induces dissociation of GRX, but not TRX, from ASK1 and
activates JNK1
(A) DU-145 cells were co-infected with Ad.HA–ASK1 at an MOI of 10, and Ad.His–GRX at
an MOI of 30 or Ad.His–TRX at an MOI of 30. After 24 h incubation, cells were treated with
medium containing GSSG ester (lanes 3 and 5) or mock medium (lanes 2 and 4) for 1 h.
Cell lysates were divided into two portions. One portion was immunoprecipitated with anti-His
antibody, and then immunoblotted with anti-HA (HA–ASK1) or anti-His antibody (His–GRX or
His–TRX). The other portion was immunoblotted with anti-HA antibody. (B) DU-145 cells were
treated with GSH ester (lane 2), H2O2 + catalase (lane 3) or GSSG ester (lane 4) for 1 h. Lysates
containing equal amounts of protein (20 µg) were separated by SDS/PAGE and immunoblotted
with anti-phospho-JNK (upper panel) or anti-JNK1 (lower panel) antibody. Lane 1, untreated
control cells. IP, immunoprecipitation.
vation (Figure 8A, lane 2 versus lane 6) as well as cytotoxicity
(Figure 8B, histogram 2 versus 6). Figure 8 also shows that BSO
enhanced glucose deprivation-induced JNK1 activation as well
as cytotoxicity (Figure 8A, lane 4; Figure 8B, histogram 4).
This enhancement was suppressed by overexpression of catalase
(Figure 8A, lane 8; Figure 8B, histogram 8). The protective effect
of catalase was dependent on MOIs (Figure 9). JNK1 activation
and cytotoxicity were effectively inhibited by increasing catalase
expression (Figures 9A and 9B). Effect of catalase on the time
course of JNK1 activation during glucose deprivation can be seen
in Figure 10. Overexpression of catalase inhibited JNK1 activation
early as well as late time period during glucose deprivation.
Overexpression of catalase inhibits dissociation of GRX and TRX
from ASK1 during glucose deprivation
We extended our studies to investigate whether overexpression of
catalase inhibits dissociation of GRX and TRX from ASK1 during
glucose deprivation. Figures 11(A) and 11(B) show that GRX
and TRX dissociated from ASK1 during glucose deprivation
(Figures 11A and 11B, lane 3). Their dissociations were prevented
by catalase overexpression (Figures 11A and 11B, lane 8). As
shown previously, dissociation of GRX, but not TRX, from
ASK1 was inhibited by treatment with BSO (Figures 11A and
11B, lane 5). Interestingly, overexpression of catalase suppressed
dissociation of TRX from ASK1 during BSO pretreatment
followed by glucose deprivation (Figure 11B, lane 10).
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Figure 8 Effect of catalase overexpression on glucose deprivation-
induced JNK1 activation in BSO-treated or -untreated cells
DU-145 cells were infected with adenoviral vectors containing green fluorescent protein
(Ad.EGFP) or catalase (Ad.Catalase) at an MOI of 5. After 24 h incubation, cells were treated
with (+) or without (–) 200 µM BSO for 24 h. (A) Cells were exposed to glucose-free medium
for 1 h and harvested. Cell lysates containing equal amounts of protein (20 µg) were separated
by SDS/PAGE and immunoblotted with anti-phospho-JNK, anti-catalase or anti-actin antibody.
(B) Cells were exposed to glucose-free medium for 24 h and then survival was determined by
the Trypan Blue exclusion assay. Asterisks indicate values different from Ad.EGFP, –glucose
control (paired t -test, P < 0.05) and error bars represent means +− standard deviation for three
separate experiments.
Glucose deprivation-induced ASK1 activation
Our results are summarized in Figure 12. They indicate that
glucose deprivation promotes the level of ROS. The elevation
of ROS may activate ASK1 through two different pathways
(glutathione-dependent GRX–ASK1 pathway and glutathione-
independent TRX–ASK1 pathway). BSO inhibits the GRX–
ASK1 pathway, but not the TRX–ASK1 pathway.
DISCUSSION
Several conclusions can be drawn after considering the results
presented. BSO, which effectively reduces the intracellular
glutathione content, enhances glucose deprivation-induced
cytotoxicity as well as JNK1 activation. This is probably due
to promotion of dissociation of TRX, but not GRX, from ASK1.
Nonetheless, catalase, an efficient scavenger of H2O2, suppresses
the effect of BSO on glucose deprivation-induced cytotoxicity,
on JNK1 activation and on dissociation of TRX from ASK1. Our
results suggest a differential role of GRX and TRX in glucose
deprivation-induced JNK1 activation.
We have reported previously that glucose deprivation results
in an increase in steady-state levels of intracellular GSSG (3–
Figure 9 Effect of catalase overexpression on glucose deprivation-
induced JNK activation in BSO-treated or -untreated cells
DU-145 cells were infected with Ad.EGFP at an MOI of 100 or Ad.Catalase at various MOIs
(1–100). After 24 h incubation, cells were treated with (+) or without (–) 200 µM BSO for
24 h. (A) Cells were exposed to glucose-free medium for 10 min and harvested. Cell lysates
containing equal amounts of protein (20 µg) were separated by SDS/PAGE and immunoblotted
with anti-phospho-JNK, anti-catalase or anti-actin antibody. (B) Cells were exposed to glucose-
free medium for 24 h and then survival was determined by the Trypan Blue-exclusion assay.
Error bars represent means +− S.D. for three separate experiments.
Figure 10 Effect of catalase overexpression on glucose deprivation-
induced JNK activation in BSO-pretreated DU-145 cells
Cells were infected with either Ad.EGFP or Ad.Catalase at an MOI of 100. After 24 h incubation,
cells were treated with (+) or without (–) 200 µM BSO for 24 h. Cells were exposed to glucose-
free medium for various time periods (5 min to 2 h). Cell lysates containing equal amounts
of protein (20 µg) were separated by SDS/PAGE and immunoblotted with anti-phospho-JNK,
anti-catalase or anti-actin antibody.
10-fold) and an increase in intracellular hydroperoxide level (2–
4-fold) as determined by increased fluorescence of an oxidation-
sensitive probe [1,2,31]. The cells also appear to respond
to glucose deprivation-induced metabolic oxidative stress by
attempting to increase the synthesis of glutathione [1,2]. However,
in the absence of substrates necessary for the regeneration of
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Figure 11 Effect of catalase overexpression on glucose deprivation-
induced dissociation of GRX (A) or TRX (B) from ASK1
DU-145 cells were co-infected with Ad.Catalase/Ad.EGFP at an MOI of 100, Ad.HA–ASK1 at an
MOI of 10 and Ad.His–GRX/Ad.His–TRX at an MOI of 30. After 24 h infection, cells were treated
with (+) or without (–) 200 µM BSO for 24 h and then exposed to glucose-free medium for
1 h. Lysates were immunoprecipitated with anti-His antibody, and immunoblotted with anti-HA
or anti-His antibody. Lysates were also immunoblotted with anti-catalase or anti-actin antibody.
IP, immunoprecipitation.
NADPH, glutathione cannot be maintained in the reduced state
[31]. In this study, we observed that the depletion of intracellular
glutathione by treatment with BSO inhibits dissociation of GRX,
but not TRX, from ASK1. These results are consistent with
our previous studies [18]. GRX, unlike TRX, probably interacts
with GSSG and forms a covalent glutathionyl-enzyme-disulphide
intermediate (GRX-SSG) and subsequently an intramolecular
disulphide form of GRX (GRX-[S-S]). The glutathionylated
GRX may dissociate from ASK1, leading to activation of
the ASK1–MEK–MAPK signal-transduction pathway. Figure 7
indeed shows that treatment of the cells with GSSG ester resulted
in dissociation of GRX from ASK1 and activation of the ASK1–
MEK–MAPK signal-transduction pathway. We believe that this
effect was due to a proportion of the exogenous GSSG ester
entering the cells and directly interacting with GRX bound to
ASK1. However, at the present time, we cannot rule out the
possibility that GSSG ester has effects at the cell surface, where it
Figure 12 A model for the mechanism of glucose deprivation-induced
ASK1 activation
may glutathionylate and/or oxidize vicinal dithiols of cell-surface
proteins, subsequently activating the ASK1–MEK–MAPK sys-
tem. Obviously, further studies at the biochemical level are
necessary to understand the role of GSSG in the GRX–ASK1
pathway. Unlike GRX, TRX may not react with glutathione-
containing mixed disulphides. TRX may directly sense H2O2
[32,33]. These results suggest that glucose deprivation-induced
signals can be intermediated through the glutathione-dependent
GRX–ASK1 pathway and the glutathione-independent pathway
(Figure 12). Interestingly, BSO alone does not lead to cytotoxicity,
ASK1/JNK activation and TRX/GRX dissociation (Figures 1–5).
These results suggest that depletion of intracellular glutathione
alone is not sufficient for inducing apoptosis. These results are
consistent with previous reports [26,34,35]. In fact, most cells
appear to be capable of tolerating a decrease in GSH levels up to
approx. 90%without adverse consequences [23]. Our results also
show that overexpression of catalase inhibits glucose deprivation-
induced JNK1 activation, cytotoxicity and dissociation of GRX
and TRX from ASK1 (Figures 8–11). Overexpression of cata-
lase also suppresses the promoting effect of BSO on glucose de-
privation. This is probably because catalase serves as a secondary
defence against ROS-induced cytotoxicity when glutathione is
depleted [22].
The results of the present study show that BSO enhances
glucose deprivation-induced JNK1 activation and cytotoxicity.
At the present time, we can only speculate on the mechanism for
effects of BSO on glucose deprivation-induced ASK1 activation.
Previous studies have shown that the kinase activity of ASK1 is
stimulated by tumour necrosis factor or Fas ligand via tumour
necrosis factor receptor-associated factor 2 (TRAF2) or death-
associated protein (Daxx) respectively [36,37]. It is well known
that TRAF2 can interact with the N- and C-terminal portions of
ASK1. The interaction of ASK1 and TRAF2 enhances ASK1
homo-oligomerization and subsequently activates ASK1 [36].
Similar to TRAF2, Daxx binds to ASK1 and activates its kinase
activity [37]. However, unlike TRAF2, Daxx translocates from the
nucleus to the cytoplasm and interacts with the death domain of
Fas and ASK1 [38–40]. Previous studies also show that ASK1
proapoptotic activity is antagonized by association of 14-3-3
proteins [41]. 14-3-3 binds to Ser967 of ASK1 and disruption of
the ASK1–14-3-3 interaction facilitates ASK1 activation [41].
We postulate that depletion of glutathione by BSO increases
the intracellular level of ROS during glucose deprivation. The
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elevated level of ROS stimulates non-receptor-associated signal
transduction and results in promotion of the TRAF2/Daxx–
ASK1 interaction or disruption of the 14-3-3–ASK1 interaction.
Although we are far from understanding how BSO enhances
glucose deprivation-induced JNK1 activation and cytotoxicity, we
postulate that TRAF2, Daxx or 14-3-3 is probably involved in the
ASK1 activation processes and BSO may affect the involvement
of these molecules. We believe that this model will provide a
framework for future studies.
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